Basit öğe kaydını göster

dc.contributor.authorSelcuk, Ilker
dc.contributor.authorOzdal, Bulent
dc.contributor.authorTurker, Mengu
dc.contributor.authorUsubutun, Alp
dc.contributor.authorGungor, Tayfun
dc.contributor.authorMeydanli, Mehmet Mutlu
dc.date.accessioned2019-12-12T06:43:20Z
dc.date.available2019-12-12T06:43:20Z
dc.date.issued2015
dc.identifier.issn2090-6684
dc.identifier.urihttps://doi.org/10.1155/2015/491875
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442002/
dc.identifier.urihttp://hdl.handle.net/11655/16800
dc.description.abstractMucoepidermoid carcinoma of uterine cervix is a rare tumor that has some individual features. Defining risk factors after surgery shape the postoperative treatment modality on cervical cancer patients. Although there is not a well-known strategy for the postoperative follow-up of mucoepidermoid carcinoma, the aggressive behaviour of this tumor makes the gynecological oncologists choose liberal therapies on these patients.
dc.relation.isversionof10.1155/2015/491875
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleMucoepidermoid Carcinoma Of Uterine Cervix: A Distinct Pathological And Clinical Entity
dc.typeinfo:eu-repo/semantics/article
dc.relation.journalCase Reports in Obstetrics and Gynecology
dc.contributor.departmentTıbbi Patoloji
dc.identifier.volume2015
dc.description.indexPubMed


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster